Your browser doesn't support javascript.
loading
Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.
Arseneault, Madeleine; Monlong, Jean; Vasudev, Naveen S; Laskar, Ruhina S; Safisamghabadi, Maryam; Harnden, Patricia; Egevad, Lars; Nourbehesht, Nazanin; Panichnantakul, Pudchalaluck; Holcatova, Ivana; Brisuda, Antonin; Janout, Vladimir; Kollarova, Helena; Foretova, Lenka; Navratilova, Marie; Mates, Dana; Jinga, Viorel; Zaridze, David; Mukeria, Anush; Jandaghi, Pouria; Brennan, Paul; Brazma, Alvis; Tost, Jorg; Scelo, Ghislaine; Banks, Rosamonde E; Lathrop, Mark; Bourque, Guillaume; Riazalhosseini, Yasser.
Afiliação
  • Arseneault M; Department of Human Genetics, McGill University, 1205 Dr Penfield Avenue, Montreal, QC, H3A 1B1, Canada.
  • Monlong J; McGill University and Genome Quebec Innovation Centre, 740 Doctor Penfield Avenue, Montreal, QC, H3A 0G1, Canada.
  • Vasudev NS; Department of Human Genetics, McGill University, 1205 Dr Penfield Avenue, Montreal, QC, H3A 1B1, Canada.
  • Laskar RS; McGill University and Genome Quebec Innovation Centre, 740 Doctor Penfield Avenue, Montreal, QC, H3A 0G1, Canada.
  • Safisamghabadi M; Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, LS9 7TF, UK.
  • Harnden P; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008 Lyon, France.
  • Egevad L; Department of Human Genetics, McGill University, 1205 Dr Penfield Avenue, Montreal, QC, H3A 1B1, Canada.
  • Nourbehesht N; McGill University and Genome Quebec Innovation Centre, 740 Doctor Penfield Avenue, Montreal, QC, H3A 0G1, Canada.
  • Panichnantakul P; Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, LS9 7TF, UK.
  • Holcatova I; Karolinska Institutet, Department of Pathology, SE-171 77 Stockholm, Sweden.
  • Brisuda A; Department of Human Genetics, McGill University, 1205 Dr Penfield Avenue, Montreal, QC, H3A 1B1, Canada.
  • Janout V; McGill University and Genome Quebec Innovation Centre, 740 Doctor Penfield Avenue, Montreal, QC, H3A 0G1, Canada.
  • Kollarova H; Department of Human Genetics, McGill University, 1205 Dr Penfield Avenue, Montreal, QC, H3A 1B1, Canada.
  • Foretova L; McGill University and Genome Quebec Innovation Centre, 740 Doctor Penfield Avenue, Montreal, QC, H3A 0G1, Canada.
  • Navratilova M; First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University in Prague, Studnickova 7, Praha 2, 128 00 Prague, Czech Republic.
  • Mates D; University Hospital Motol, V Úvalu 84, 150 06 Prague, Czech Republic.
  • Jinga V; Department of Preventive Medicine, Faculty of Medicine, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic.
  • Zaridze D; Department of Preventive Medicine, Faculty of Medicine, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic.
  • Mukeria A; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Zluty Kopec 7, 656 53 Brno, Czech Republic.
  • Jandaghi P; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Zluty Kopec 7, 656 53 Brno, Czech Republic.
  • Brennan P; National Institute of Public Health, Dr Leonte Anastasievici 1-3, sector 5, Bucuresti 050463, Romania.
  • Brazma A; Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, 20 Panduri Street, 050659 Bucharest, Romania.
  • Tost J; Russian N.N. Blokhin Cancer Research Centre, Kashirskoye shosse 24, Moscow 115478, Russian Federation.
  • Scelo G; Russian N.N. Blokhin Cancer Research Centre, Kashirskoye shosse 24, Moscow 115478, Russian Federation.
  • Banks RE; Department of Human Genetics, McGill University, 1205 Dr Penfield Avenue, Montreal, QC, H3A 1B1, Canada.
  • Lathrop M; McGill University and Genome Quebec Innovation Centre, 740 Doctor Penfield Avenue, Montreal, QC, H3A 0G1, Canada.
  • Bourque G; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008 Lyon, France.
  • Riazalhosseini Y; European Molecular Biology Laboratory, European Bioinformatics Institute, EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, CB10 1SD, UK.
Sci Rep ; 7: 44876, 2017 03 23.
Article em En | MEDLINE | ID: mdl-28332632
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Regulação Neoplásica da Expressão Gênica / Antígenos de Histocompatibilidade Menor / Deleção Cromossômica / Cromossomos Humanos Y / Epigênese Genética / Histona Desmetilases / Neoplasias Renais Limite: Female / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Regulação Neoplásica da Expressão Gênica / Antígenos de Histocompatibilidade Menor / Deleção Cromossômica / Cromossomos Humanos Y / Epigênese Genética / Histona Desmetilases / Neoplasias Renais Limite: Female / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido